Anti-Human TNC Recombinant Antibody (F16-131I)

CAT#: TAB-622CL

Recombinant Human monoclonal antibody expressed in CHO binding to Human TNC. The monoclonal antibodiess F16-131I specific to F16 (specific to the A1 domain of tenascin-C) are currently investigated in Phase I and Phase II clinical trials in patients with cancer and with rheumatoid arthritis.

Gene Expression
Figure 1 Cerebral cortex Figure 2 Kidney Figure 3 Testis Figure 4 RNA cell line category: Cell line enhanced.

Specifications

  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • Antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Hematologic Malignancies; Solid Tumors

Product Property

  • Purity
  • >95% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE
  • Storage
  • ≤6 months at 4°C; ≥6 months at -20°C.

Target

  • Alternative Names
  • TNC; tenascin C; GP; JI; TN; HXB; GMEM; TN-C; DFNA56; 150-225; tenascin; GP 150-225; cytotactin; neuronectin; myotendinous antigen; hexabrachion (tenascin); tenascin-C isoform 14/AD1/16; tenascin-C additional domain 1; deafness, autosomal dominant 56; gli
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-622CL. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Reliable Research Tool
I have been using the Anti-TNC Therapeutic Antibody F16-131I in my research for over six months, and the results have been consistently reliable. The antibody binds specifically to TNC, which is critical in studying tumors. Its I-131 label enhances detection in imaging assays, and I have observed excellent consistency across multiple batches. This tool has become indispensable for our studies on tumor microenvironments and extracellular matrix remodeling, and it has significantly improved the clarity of our experimental data.
Breast cancer biomarkers at key points during disease progression
Robust Performance
This antibody has consistently provided robust performance across our research projects. Its ability to accurately detect the TNC antigen has been highly beneficial when analyzing cancer models and cell culture systems. The enhanced detection enabled by the I-131 label has improved our imaging studies, ensuring that our data is both precise and repeatable.

Q&As

  1. What does the Anti-TNC Therapeutic Antibody F16-131I target and how is it used in research?

    A: This antibody is designed to bind to the TNC (Tenascin-C) antigen, a protein that is often overexpressed in the extracellular matrix of tumors and involved in tissue remodeling. It is used in research to study the behavior and distribution of TNC in various cancers and tissue models. The product is part of a high-quality recombinant portfolio and is radiolabeled with I-131 to facilitate tracking and detection in experimental settings.

  2. Why is the TNC antigen an important target in research, particularly in cancer studies?

    A: TNC, or Tenascin-C, is an extracellular matrix protein that is significantly upregulated in many types of tumors. Studying TNC helps researchers understand its role in influencing cell adhesion, migration, and tissue invasion during cancer progression. The Anti-TNC Therapeutic Antibody F16-131I enables precise detection and quantification of TNC in tumor samples, providing insights into its potential as a marker for tumor aggression and as a tool to study matrix remodeling in cancer research.

View the frequently asked questions answered by Creative Biolabs Support.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-622CL, RRID: AB_3111980)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Tnc"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-877 Anti-Human Tenascin C/TNC Recombinant Antibody (Tenatumomab) IHC IgG2b
CAT Product Name Application Type
BRD-0810MZ Chicken Anti-Tenascin C Polyclonal IgY WB Chicken antibody
BRD-0910MZ Chicken Anti-Tenascin C Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
NEUT-2050CQ Rat Anti-TNC Recombinant Antibody (clone CBL402) WB, ICC, Neut Rat IgG2a
CAT Product Name Application Type
MOR-3601 Rabbit Anti-TNC Recombinant Antibody (clone DS3601AB) WB, IHC, ICC Rabbit IgG
CAT Product Name Application Type
AFC-TAB-877 Afuco™ Anti-TNC ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-877) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0425-FY187 Human Anti-TNC (clone F16-131I) scFv-Fc Chimera IHC Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare